{"timestamp": 1771602687.5550945, "value": {"ticker": "INMB", "company_name": "INmune Bio Inc.", "short_name": "INmune Bio Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 35334468, "float_shares": 20608626, "shares_outstanding": 26585258, "short_ratio": 11.65, "short_percent_of_float": 0.1992, "shares_short": 4047425, "shares_short_prior": 3241827, "insider_percent_held": 0.17011, "institution_percent_held": 0.18114, "total_cash": 27734000, "total_debt": 1080000, "total_revenue": 50000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 1.0, "operating_margins": -697.24, "debt_to_equity": 4.256, "current_ratio": 4.169, "book_value": 0.955, "price_to_book": 1.3917278, "operating_cashflow": -30651000, "free_cashflow": -19256876, "price": 1.3291, "52w_high": 11.64, "52w_low": 1.275, "avg_volume": 393288, "avg_volume_10d": 306430, "full_time_employees": 13, "audit_risk": 9, "overall_risk": 6}}